What is NDC 25021-311?

25021-311 is the product NDC for Furosemide, Furosemide 10 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 3 package NDCs, shown above in 10- and 11-digit form.

Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Furosemide?

211 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Furosemide NDC 25021-311 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-311Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0311Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
25021-311-02	25021031102	25 VIAL in 1 CARTON (25021-311-02) / 2 mL in 1 VIALMarketed from Mar 15, 2021
25021-311-04	25021031104	25 VIAL in 1 CARTON (25021-311-04) / 4 mL in 1 VIALMarketed from Mar 15, 2021
25021-311-10	25021031110	25 VIAL in 1 CARTON (25021-311-10) / 10 mL in 1 VIALMarketed from Mar 15, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 10 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Sagent PharmaceuticalsNDC labeler code 25021
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213902
Marketing start: Mar 15, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 25021-311_222ce48f-2856-4be2-b16f-6fca38c0dcebSPL ID 222ce48f-2856-4be2-b16f-6fca38c0dcebSPL set ID d63c1277-dd7e-4d21-9e80-68143f55e2dcRxCUI 1719286, 1719290, 1719291UNII 7LXU5N7ZO5
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021031102 followed by a unit qualifier and the quantity

Package 25021-0311-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 29, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Furosemide is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of furosemide is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema. If gastrointestinal absorption is impair…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 25021-311

What is NDC 25021-311?: 25021-311 is the product NDC for Furosemide, Furosemide 10 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Furosemide.
What is the active ingredient?: Furosemide.
Who is the labeler?: Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Furosemide?: 211 other product NDCs are listed under this name. See all Furosemide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Furosemide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Furosemide	Furosemide 10 mg/mL	InjectionIntramuscular, Intravenous	Civica, Inc.	72572-275	72572-0275-10
Furosemide	Furosemide 20 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-033	87441-0033-01
Furosemide	Furosemide 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4679	70518-4679-00
Furosemide	Furosemide 20 mg/1	TabletOral	Coupler LLC	67046-0768	67046-0768-03
Furosemide	Furosemide 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4609	70518-4609-00
Furosemide	Furosemide 40 mg/1	TabletOral	Coupler LLC	67046-1663	67046-1663-03
Furosemide	Furosemide 20 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-832	10135-0832-0110135-0832-1010135-0832-90
Furosemide	Furosemide 40 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-833	10135-0833-0110135-0833-1010135-0833-90
Furosemide	Furosemide 80 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-834	10135-0834-0110135-0834-0510135-0834-90
Furosemide	Furosemide 20 mg/1	TabletOral	Granulation Technology, Inc.	63561-0164	63561-0164-0163561-0164-0263561-0164-09

All 212 Furosemide NDCs

Other NDCs under ANDA 213902

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213902
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Gland Pharma Limited	68083-432
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Gland Pharma Limited	68083-433
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Gland Pharma Limited	68083-434